The emperor has no symptoms: the risks of a blanket approach to using epinephrine autoinjectors for all allergic reactions

Files in this item

This item appears in the following Collection(s)

©2016 The Authors. Published by Elsevier Inc. on behalf of the American Academyof Allergy, Asthma & Immunology. This is an open access article under the CCBY license (http://creativecommons.org/licenses/by/4.0/).http://dx.doi.org/10.1016/j.jaip.2016.05.0051143 Except where otherwise noted, this item's license is described as ©2016 The Authors. Published by Elsevier Inc. on behalf of the American Academyof Allergy, Asthma & Immunology. This is an open access article under the CCBY license (http://creativecommons.org/licenses/by/4.0/).http://dx.doi.org/10.1016/j.jaip.2016.05.0051143
This website uses cookies. By using this website, you consent to the use of cookies in accordance with the UCC Privacy and Cookies Statement. For more information about cookies and how you can disable them, visit our Privacy and Cookies statement